220 related articles for article (PubMed ID: 16799145)
1. Association between serum beta-carotene levels and decline of cognitive function in high-functioning older persons with or without apolipoprotein E 4 alleles: MacArthur studies of successful aging.
Hu P; Bretsky P; Crimmins EM; Guralnik JM; Reuben DB; Seeman TE
J Gerontol A Biol Sci Med Sci; 2006 Jun; 61(6):616-20. PubMed ID: 16799145
[TBL] [Abstract][Full Text] [Related]
2. The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents.
Fillenbaum GG; Landerman LR; Blazer DG; Saunders AM; Harris TB; Launer LJ
J Am Geriatr Soc; 2001 Sep; 49(9):1148-55. PubMed ID: 11559372
[TBL] [Abstract][Full Text] [Related]
3. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.
Haan MN; Shemanski L; Jagust WJ; Manolio TA; Kuller L
JAMA; 1999 Jul; 282(1):40-6. PubMed ID: 10404910
[TBL] [Abstract][Full Text] [Related]
4. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
Qiu C; Winblad B; Fratiglioni L
Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
[TBL] [Abstract][Full Text] [Related]
5. The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging.
Bretsky P; Guralnik JM; Launer L; Albert M; Seeman TE;
Neurology; 2003 Apr; 60(7):1077-81. PubMed ID: 12682309
[TBL] [Abstract][Full Text] [Related]
6. Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study.
Dik MG; Deeg DJ; Bouter LM; Corder EH; Kok A; Jonker C
Stroke; 2000 Oct; 31(10):2431-6. PubMed ID: 11022076
[TBL] [Abstract][Full Text] [Related]
7. Effect of plasma lipids, hypertension and APOE genotype on cognitive decline.
Yasuno F; Tanimukai S; Sasaki M; Ikejima C; Yamashita F; Kodama C; Hidaka S; Mizukami K; Asada T
Neurobiol Aging; 2012 Nov; 33(11):2633-40. PubMed ID: 22285757
[TBL] [Abstract][Full Text] [Related]
8. Cognitive decline in high-functioning older persons is associated with an increased risk of hospitalization.
Chodosh J; Seeman TE; Keeler E; Sewall A; Hirsch SH; Guralnik JM; Reuben DB
J Am Geriatr Soc; 2004 Sep; 52(9):1456-62. PubMed ID: 15341546
[TBL] [Abstract][Full Text] [Related]
9. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.
van Vliet P; Oleksik AM; Mooijaart SP; de Craen AJ; Westendorp RG
Neurology; 2009 Mar; 72(9):821-8. PubMed ID: 19255409
[TBL] [Abstract][Full Text] [Related]
10. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status.
Graves AB; Bowen JD; Rajaram L; McCormick WC; McCurry SM; Schellenberg GD; Larson EB
Neurology; 1999 Oct; 53(7):1480-7. PubMed ID: 10534255
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
[TBL] [Abstract][Full Text] [Related]
12. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E, cardiovascular disease and cognitive function in aging women.
Kang JH; Logroscino G; De Vivo I; Hunter D; Grodstein F
Neurobiol Aging; 2005 Apr; 26(4):475-84. PubMed ID: 15653176
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults.
Swan GE; Lessov-Schlaggar CN; Carmelli D; Schellenberg GD; La Rue A
J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):196-201. PubMed ID: 16306239
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample.
Henderson AS; Easteal S; Jorm AF; Mackinnon AJ; Korten AE; Christensen H; Croft L; Jacomb PA
Lancet; 1995 Nov; 346(8987):1387-90. PubMed ID: 7475820
[TBL] [Abstract][Full Text] [Related]
16. The apolipoprotein E epsilon 2 allele and decline in episodic memory.
Wilson RS; Bienias JL; Berry-Kravis E; Evans DA; Bennett DA
J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):672-7. PubMed ID: 12438469
[TBL] [Abstract][Full Text] [Related]
17. Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins.
Carmelli D; Swan GE; Reed T; Miller B; Wolf PA; Jarvik GP; Schellenberg GD
Neurology; 1998 Jun; 50(6):1580-5. PubMed ID: 9633697
[TBL] [Abstract][Full Text] [Related]
18. Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men.
Kalmijn S; Feskens EJ; Launer LJ; Kromhout D
Stroke; 1996 Dec; 27(12):2230-5. PubMed ID: 8969786
[TBL] [Abstract][Full Text] [Related]
19. Dietary fats and the APOE-e4 risk allele in relation to cognitive decline: a longitudinal investigation in a biracial population sample.
Liu X; Beck T; Dhana K; Tangney CC; Desai P; Krueger K; Evans DA; Rajan KB
J Nutr Health Aging; 2024 May; 28(5):100211. PubMed ID: 38507884
[TBL] [Abstract][Full Text] [Related]
20. Education and APOE-e4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging.
Seeman TE; Huang MH; Bretsky P; Crimmins E; Launer L; Guralnik JM
J Gerontol B Psychol Sci Soc Sci; 2005 Mar; 60(2):P74-83. PubMed ID: 15746021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
